Using a hemodynamic monitoring system to reduce anesthetic use during abdominal surgery
Impact of Using an Hemodynamic Monitoring System on Anesthetic Consumption During Abdominal Surgery
This study tests if using a special monitoring system during abdominal surgery can help reduce the amount of anesthesia needed for patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 84 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Roma) |
| Trial ID | NCT06439732 on ClinicalTrials.gov |
What this trial studies
This study investigates how a hemodynamic monitoring system affects the amount of anesthetic consumed during major abdominal surgeries. Patients will be randomly assigned to either a control group, which uses a non-invasive intermittent pressure system, or an intervention group, which uses a continuous monitoring system with the Acumen IQ cuff sensor. The primary outcome will be the total volume of Sevoflurane used in each group, allowing researchers to assess the impact of continuous monitoring on anesthetic consumption.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who can provide informed consent and do not have significant comorbidities.
Not a fit: Patients with a BMI over 30, severe cardiac conditions, or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to reduced anesthetic use and improved patient outcomes during abdominal surgeries.
How similar studies have performed: While the specific approach of this study may be novel, similar studies have shown that hemodynamic monitoring can improve outcomes in surgical settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * over 18 years of age * signature of informed medical consent Exclusion Criteria: * BMI\> 30 * eGFR\<30 * NYHA III-IV * severe cardiac valvular diseases * absence of informed medical consent
Where this trial is running
Roma
- Fondazione Policlinico Universitario "A. Gemelli" IRCCS — Roma, Italy (Recruiting)
Study contacts
- Principal investigator: Andrea Russo, MD — Fondazione Policlinico universitario Agostino Gemelli
- Study coordinator: Andrea Russo, MD
- Email: russoandreamd@gmail.com
- Phone: 0630154507
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.